Introduction: No recent studies to determine the prevalence of neurological disorders due to Vitamin B12 deficiency from India.
Materials and Methods: This was a prospective and observational outpatient-based study in a tertiary care hospital between July 2015 and November 2016. The study included patients ≥18 years of age presenting with acral paresthesias and other neurologic symptoms. Patients with: (1) neurological syndromes due to systemic, toxic, and neurodegenerative diseases; (2) neuropathy due to other causes; and (3) compressive neuropathies were excluded. All patients enrolled in the study underwent detailed clinical examination. Cognitive screening was done using Mini–Mental State Examination and neuropsychological testing when required. Neuropathy scores were assessed by Clinical Neurological Examination Score and Toronto Clinical Scoring system. Serum B12 testing was estimated by Automated Immunoassay Analyzer, deficiency defined as <250 pg/ml. Electrodiagnostic tests were done using conventional technique. Magnetic resonance imaging of the spine and brain was done whenever needed.
Results: Of 7100 new outpatient visits, 92 (1.9%) had B12 deficiency. Acral paresthesias was presenting symptom in 910 (12.8%) patients and 61 of them had B12 (6.7%) deficiency. Among 92 patients with B12 deficiency, 31 (33, 7%) had specific neurological syndromes and 61 (66.3%) had subjective acral paresthesias with no clinical or electrodiagnostic abnormalities. The prevalence of Vitamin B12 deficiency in this study population was 12.95/1000 and among patients with acral paresthesias, it was 67/1000. Prevalence-specific neurologic syndromes were 4.36/1000.
Conclusion: B12 deficiency is not uncommon among patients attending neurologic clinics. It is prudent to estimate B12 in patients with paresthesis.
